Can-Fite BioPharma Ltd. Research And Development Expense

• Can-Fite BioPharma Ltd. showed an increase of +16.3% in Research And Development Expense from 2024 to 2025.
• This data is from Can-Fite BioPharma Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Can-Fite BioPharma Ltd.'s Research And Development Expense has grown by 10.2%.
• Historical annual values: Fiscal year 2025: $6.69 million | Fiscal year 2024: $5.76 million | Fiscal year 2023: $5.98 million | Fiscal year 2022: $7.76 million | Fiscal year 2021: $9.85 million | Fiscal year 2020: $11.95 million | Fiscal year 2019: $10.98 million | Fiscal year 2018: $6.08 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026